-

Anaergia Announces It Will File Fourth Quarter and Year-end 2022 Financial Statements on March 30, 2023

BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) announced today that it will be filing its audited fourth quarter and year-end annual financial statements, management's discussion and analysis and related certifications for its fourth quarter and fiscal year ended December 31, 2022, on March 30, 2023. Management’s conference call to discuss these results will now occur on March 31, 2023.

Due to the growth of the company and the corresponding complexity of the financial statements, the Company’s auditors, KPMG LLP, require a few more days to complete the audit than in previous years.

About Anaergia

Anaergia was created to eliminate a major source of greenhouse gases by cost effectively turning organic waste into renewable natural gas (RNG), fertilizer and water, using proprietary technologies. With a proven track record from delivering world-leading projects on four continents, Anaergia is uniquely positioned to provide end-to-end solutions for extracting organics from waste, implementing high efficiency anaerobic digestion, upgrading biogas, producing fertilizer and cleaning water. Our customers are in the municipal solid waste, municipal wastewater, agriculture, and food processing industries. In each of these markets Anaergia has built many successful plants including some of the largest in the world. Anaergia owns and operates some of the plants it builds, and it also operates plants that are owned by its customers.

Forward-Looking Information

This news release contains forward-looking information within the meaning of applicable securities legislation, which reflects the Company’s current expectations regarding future events, including statements relating to the Company’s process to obtain the Potential Financial. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond the Company’s control. Such risks and uncertainties include, but are not limited to, the factors discussed under “Risk Factors” in the Company’s annual information form dated March 28, 2022, for the fiscal year ended December 31, 2021. Actual results could differ materially from those projected herein. Anaergia does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required under applicable securities laws.

For more information, please see: www.anaergia.com

Contacts

For media relations, please contact: Melissa Bailey, Director, Marketing & Corporate Communications, Melissa.Bailey@Anaergia.com

For investor relations, please contact: IR@Anaergia.com

Industry:

Anaergia Inc.

TSX:ANRG
Release Versions
English

Contacts

For media relations, please contact: Melissa Bailey, Director, Marketing & Corporate Communications, Melissa.Bailey@Anaergia.com

For investor relations, please contact: IR@Anaergia.com

More News From Anaergia Inc.

Anaergia Signs Definitive Agreement to Divest Non-Core Assets, Charlotte and Rhode Island Bioenergy Facilities

CARLSBAD, California & BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG; OTCQX: ANRGF) announced today that certain of its affiliates, together with IIF Anaergia HoldCo, LLC (“North Sky”), have entered into a definitive Master Purchase Agreement (the “Agreement”). Under the Agreement, the buyer has acquired the assets of Charlotte Bioenergy Facility (“CBF”) in Charlotte, North Carolina, and 100% interests in the Rhode Island Bioenergy Facility HoldCo,...

Anaergia and TisVet Sign C$36 million Technology Agreement for Major Agricultural-Waste-to-Energy Project in Hungary

TREVIGLIO, Italy & BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) (OTCQX: ANRGF), through its subsidiary Anaergia Srl, and TisVet Kft (“TisVet”), one of Hungary’s largest duck, and other poultry, producers, have entered into an agreement, under which Anaergia Srl is to supply technology and engineering services for a new anaerobic digestion facility in Hungary, subject to the satisfaction of certain conditions precedent agreed between Anaergia and...

Anaergia Reports 98% Revenue Growth, Fourth Consecutive Quarter of Positive Adjusted EBITDA, and Revenue Backlog Expansion to $274.9 Million in Q2 2026

BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia (TSX: ANRG, OTCQX: ANRGF) Q2 2026: revenue up 98% to $63.9M, fourth consecutive quarter of positive Adjusted EBITDA, Revenue Backlog $274.9M....
Back to Newsroom